ClinicalTrials.Veeva

Menu

Blood Collection From Heart Failure Patients to Evaluate for Galectin-3 Measurement Differences Using Various Collection Tubes

F

Fujirebio Diagnostics

Status

Completed

Conditions

To Measure Galectin-3 in Heart Failure Patients on Commercial Platforms

Study type

Observational

Funder types

Industry

Identifiers

Details and patient eligibility

About

Single-site blood collection investigation.

Full description

45 Heart Failure patients will be recruited. Patients will provide a one-time blood sample specimen collection. Theses samples will be de-identified and provided for measurement of Galectin-3 on commercial platforms.

Enrollment

48 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Heart Failure patients New York Heart Association class able to provide (4) collection tube types Subjects > 18 years old All subjects must provide informed consent and associated documentation

Exclusion criteria

  • Subjects that cannot tolerate blood withdrawal of 4 specimens collection tube tubes (approximately 40 mLs)

Trial design

48 participants in 1 patient group

Heart Failure patients
Description:
No interventions for this study. Blood draw provided by patients.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems